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Introduction
Application of knowledge is one of the core attributes of 
graduates from pharmacy schools in Australia and 
worldwide. For all pharmacy schools in Australia, the 
graduate qualities or ‘attributes’, which consistently 
encompass problem-solving skills, align well with the 
precisely articulated goal of educating prospective 
pharmacists who are expected to have both sound 
pharmaceutical knowledge and a set of skills to enable 
effective and safe professional practice. Problem solving 
will require that graduates are able to apply, analyse and 
synthesise information. The Pharmaceutical Society of 
A u s t r a l i a i n ‘ C o m p e t e n c y S t a n d a r d s f o r 
Pharmacists’ (Competency Standards for Pharmacists in 
Australia,  2016; p.19) has highlighted within their key 
statement for the profession “effective communication, 
organisational and interpersonal skills, effective 
reasoning, judgment, analytical and problem solving 
skills, with an ethical and professional attitude …” as 
essential to the profession of pharmacy. The Graduate 
Attributes of the Australian Undergraduate Pharmacy 
Programme are set and reviewed by The Australian 
School of Animal and Veterinary Sciences, The University of Adelaide,  Roseworthy Campus, Roseworthy, Australia & 
School of Environmental and Life Sciences, Pharmacy Discipline, Charles Darwin University, Darwin, Australia
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Pharmacy Council, who approves and provides 
accreditation to pharmacy programmes within Australia.
An early study conducted in the School of Pharmacy and 
Medical Sciences, The University of South Australia had 
reported the use of multiple-choice questions (MCQs) as 
a feasible approach to assess the application of 
knowledge in pharmacology courses (Stupans, 2006). 
This article describes a study, which examines the use of 
MCQs to assess the application of knowledge in two 
pharmaceutical courses of the Pharmacy programme in 
the Northern Territory, Australia.  Studies to examine the 
use of MCQ-format to assess higher cognitive thinking 
skills in pharmacy teaching other than in pharmacology 
courses will be of important value, as MCQs would offer 
an ideal assessment approach to assess large quantities of 
course materials. 
It has been well reported that MCQs can be used 
successfully to assess ‘body of knowledge’  or knowledge 
recall in pharmacology teaching (Stupans, 2006). MCQ-
format offers an effective approach to assess a large 
content of course materials and provides quick results as 
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MCQs can be marked electronically (Collins, 2014; 
Pugha et al., 2016). It is feasible to design well-
constructed MCQs for assessing higher cognitive 
thinking based on cognitive models, which are currently 
available (Case & Swanson, 2002; Touchie, 2010; 
Haladyna, 2013; Collins,  2014; Pugha et al.,  2016). 
Examples of such cognitive models include the Millers 
triangle (Millers, 1990) and Bloom’s taxonomy (Bloom 
et al.,  1956).  Traditionally, Miller’s pyramid comprised 
of four levels of cognitive thinking, including ‘knows’, 
‘knows how’, ‘shows how’, and ‘does’. Recently, two 
more underpinning awareness levels that often occur 
before we ‘know’ have been suggested to be included in 
the Miller’s pyramid, which included ‘heard of’ and 
‘knows about’. The first two stages,  ‘knows’ and ‘knows 
how’,  can be practically assessed using the traditional 
assessment tools of oral tests or written exams such as 
MCQ exams (Millers, 1990). While ‘knowing’ and 
‘knowing how’ might not always necessarily extrapolate 
to the application of knowledge in clinical settings, they 
can feasibly extrapolate to the application of knowledge 
in teaching and learning assessments.
Recent study by Zaidi and colleagues (2017) has shown 
that Bloom’s taxonomy has been used to identify MCQs 
that assess students’ critical thinking skills and provided 
good evidence suggesting that higher-order MCQs 
support a deeper conceptual understanding of scientific 
knowledge process skills. Moreover,  the use of automatic 
item generation, in which computer technology is used to 
develop MCQs from cognitive models has also been 
shown to produce MCQs with psychometric properties 
comparable to those generated using a traditional 
approach and can be used to assess higher order skills or 
‘application of knowledge’ (Pugha et al., 2016). 
While the use of MCQs to assess higher cognitive 
thinking has been explored and also applied widely in 
undergraduate, post-graduate medical teaching and board 
examinations,  few studies have been conducted in 
pharmacy to investigate the use of MCQs to assess 
higher cognitive thinking (Stupans, 2006; Palmer & 
Devitt, 2007).  While Stupans’  study focussed on the 
assessment of application of knowledge by local students 
versus international students, the study by Palmer & 
Devitt compared MCQs versus written essay to assess 
higher cognitive thinking in medical and surgery 
teaching. The current study is the first study in the last 
decade, which seeks to evaluate the use of MCQ-format 
to assess the application of knowledge of pharmaceutical 
science subject materials in pharmacy, with a focus on 
local students.
Methods 
MCQs were developed and ranked as knowledge recall 
(K) or application of knowledge (A), based on different 
levels of cognitive thinking as defined in the literature 
(Mislevy et al.,  2000; Case & Swanson, 2002; Palmer & 
Devitt, 2007; Freiwald et al., 2014). The MCQs were 
ranked independently by the academic staff responsible 
for the delivery of the corresponding lecture contents 
(Staff 1) and by two other academic staff in a ‘blind’ 
manner as previously described (Stupans,  2006).  These 
two academic staff had taught in the Pharmacy 
programme, but did not teach these courses and did not 
deliver the corresponding lecture material (Staff 2 and 3). 
All academics were advised not to discuss their 
allocation of K MCQs versus A MCQs with other staff. 
Selected MCQs were included in the final examinations 
of two pharmacy courses, namely Pharmaceutics, and 
Medicinal Chemistry and Pharmacogenetics. The course 
Pharmaceutics was one of four core subjects being 
offered in the 3rd year of the programme, which covered 
more advanced knowledge on drug delivery systems, 
their clinical uses and application. The course Medicinal 
Chemistry and Pharmacogenetics was one of the four key 
subjects being delivered in the 2nd year of the 
programme, which consisted of both basic and advanced 
medicinal chemistry knowledge. A total of 37 MCQs 
were used in the Medic inal Chemis t ry and 
Pharmacogenetics exam. Thirty-six MCQs were included 
in the Pharmaceutics exam. The exams were then 
administered to the 3rd year and 2nd year pharmacy 
students, respectively of the pharmacy programme at 
Charles Darwin University (CDU), Northern Territory, 
Australia.  The 3rd year pharmacy students involved in 
this study were the first 3rd year student cohort of the 
CDU Pharmacy programme, which achieved full 
accreditation in 2009. The study was approved by the 
Pharmacy Discipline,  School of Environmental and Life 
Sciences, Charles Darwin University.
In the current study, all MCQs were validated based on 
the analysis of the students’ overall results, in which each 
of the questions was expected to provide the percentage 
of students selecting the correct answers between 
20%-80% (Case & Swanson, 2002; Freiwald et al., 
2014). All MCQs that were included in the two exams 
met this criterion. Examples of K versus A MCQs are 
provided in the Appendix. The selected MCQs used in 
this study had also been previously developed for final 
exams of similar courses, and had been used previously 
in the final exams of these courses for a Pharmacy 
programme at a different university. The use of these 
MCQs had not been analysed previously. 
Statistical analyses of the students’ results in the two 
exams were performed using Student’s t-test. The 
differences in the percentage of students who obtained a 
correct answer for all MCQs, compared to the percentage 
of students who obtained a correct answer for K MCQs 
and the percentage of students who obtained a correct 
answer for A MCQs were considered to be significant at 
p<0.05.
Results  
Analyses of the data obtained for the two exams, with the 
percentages of students who obtained a correct answer 
for each type of the questions are shown in Table I. The 
percentage of students who obtained a correct answer for 
K MCQs compared to that of students who obtained a 
correct answer for A MCQs are also shown. 
Can MCQs assess application of knowledge? 204
Table I: Data (presented as mean ± SD) showing percentages of  students who obtained a correct answer for each 
type of MCQs 
Exams  Med Chem PGx Exam(2nd Year Pharmacy)
p-values Pharmaceutics Exam
(3rd Year Pharmacy) 
p-values
(%) Correct all MCQs
All MCQs number (No)
66.22 ± 26.00
37       
 60.86 ± 26.51
36
(%) Correct K MCQs (Staff 1, 2)
K MCQ No
 68.75 ± 11.62
20 0.149












(%) Correct A MCQs (Staff 1, 2)
A MCQ No
  63.24 ± 12.06
17 0.469
a 54.04 ± 15.13
18 0.145
a
(%) Correct A MCQs (Staff 3)
A MCQ No
 64.48 ± 16.80
11 0.311
a 78.18 ± 18.88
5 0.012
a
*Statistical analysis was performed using Student’s t-test, the difference was considered to be significant at p<0.05 
aCompared to percentage of students obtained a correct answer for all MCQs 
bDifference in the percentage of students obtained a correct answer for K MCQs compared to that of students obtained a correct answer for A MCQs.
#Statistically significant at p<0.05 compared between the percentage of students obtained a correct answer for K MCQs versus that of students obtained a correct answer 
for A MCQs.
As shown in Table I, for the Medicinal Chemistry and 
Pharmacogenetics final exam, no significant differences 
were observed in the percentage of students who 
obtained a correct answer for all MCQs compared to the 
percentage of students who obtained a correct answer for 
K MCQs. Similarly, the percentage of students who 
obtained a correct answer for K MCQs was not 
significantly different to the percentage of students who 
obtained a correct answer for A MCQs (p>0.05). The 
mean percentage of students who obtained a correct 
answer for all 37 MCQs was 66.22%, Standard Deviation 
(SD) was 26.00,  whereas the mean percentage of 
students who obtained a correct answer for A MCQs was 
63.24% (SD = 12.06), 64.48% (SD = 16.80),  (ranked by 
Staff 1, 2 versus Staff 3, respectively), and that of 
students who obtained a correct answer for K MCQs was 
68.75% (SD = 11.62), 65.4% (SD = 12.10). 
For the Pharmaceutics exam, the mean percentage of 
students who obtained a correct answer for all 36 MCQs 
was 60.86% (SD = 26.51) whereas that of students who 
obtained a correct answer for K MCQs was 67.68% (SD 
= 15.48) versus 61.29% (SD = 14.99) (ranked by Staff 1 
and 2 versus Staff 3 respectively) (p>0.05).  A significant 
higher mean percentage of students who obtained a 
correct answer for A MCQs (ranked by Staff 3) compared 
to that of students who obtained a correct answer for all 
36 MCQs was obtained, which was 78.18% (SD = 18.88) 
(p=0.012, reached statistical significance at p<0.05). 
Overall, for MCQs allocated by Staff 1 and 2, compared 
to the 2nd year student results, the percentage of students 
who obtained a correct answer for A MCQs in the 3rd 
year exam was lower, which was unexpected. As 3rd year 
students have already been taught both basic and applied 
Pharmaceutics in the 2nd year, and these student are more 
advanced stage students currently in their final year of 
the programme, it would be fair to expect that they 
should perform better in critical thinking skills, 
compared to more junior 2nd year students. For MCQs 
allocated by Staff 3, compared to the 2nd year student 
results, the percentage of students who obtained a correct 
answer for A MCQs in the 3rd year exam was higher, 
which was as expected.
In addition, great disparity in the allocation of A versus K 
MCQs was observed in both exams, with 13 more MCQs 
allocated as A in the 3rd year exam and 6 more MCQs 
allocated as A in the 2nd year exam by Staff 1 and 2 
compared to Staff 3.  This was not expected. Moreover, it 
might not be ideal to complete the comparison based on 
different number of questions allocated to A and K. This 
disparity and how it may have affected the overall results 
are further discussed below.
Discussion 
It has been well reported that MCQs can be used 
successfully for assessing students’ body of knowledge in 
both pharmacy and other related disciplines. Whether 
MCQs can also be used successfully for assessment of 
higher cognitive thinking skills is currently not well 
documented. Although this has been well explored in 
medical teaching and medical board examinations, little 
information is available in pharmacy literature. The 
current study is the first to investigate the use of MCQ-
format for assessments of pharmaceutical science subject 
materials. 
In the Medicinal Chemistry and Pharmacogenetics exam, 
the finding that there were no significant differences in 
the percentage of students who obtained a correct answer 
for MCQs that were allocated as K compared to the 
percentage of students who obtained a correct answer for 
MCQs that were allocated as A was consistent with 
previous studies. For example, Stupans (2006) had 
reported that MCQs designed as A provided consistent 
results to MCQs aimed to assess K. The findings in this 
study showed good evidence that MCQs can assess 
higher cognitive thinking, rather than just recall or 
memorising skills.  The study by Stupans also found the 
disparity in questions allocated as A or K could result in 
greatly inconsistent findings and it is extremely difficult 
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to draw firm conclusions. This was also consistent with 
the results of the current study. While Stupans' study 
compared critical thinking skills between international 
versus local students in pharmacology teaching, with a 
slight focus on English proficiency, the current study 
examined the use of MCQs to assess the A in 
pharmaceutical courses,  with a focus on local pharmacy 
students. Another previous study had also examined 
MCQs to assess higher cognitive thinking (Palmer & 
Devitt, 2007),  however this study compared MCQs to 
essay writing, which is not the same objective as that of 
the current study.
In the current study, a marked difference in the allocation 
of A MCQs versus K MCQs between staff was observed 
in the Pharmaceutics exam. A total of 18 MCQs were 
ranked as A by two academics, whereas, only five MCQs 
were ranked as A by the other staff. Although these five 
A MCQs were among those 18 A MCQs ranked by the 
two academics, this raises considerable concerns as to 
whether the great disparity in K versus A MCQs ranking 
may have affected the overall assessment of the 
Pharmaceutics exam. 
A significant difference in the mean percentage of 
students who obtained a correct answer for A MCQs 
compared to that of students who obtained a correct 
answer for K MCQs was also observed in the 
Pharmaceutics exam. The students’ overall results for this 
exam were also inconsistent.  These inconsistent findings 
possibly resulted from the marked differences in the 
allocation of A versus K MCQs in this exam. Thus 
further follow-up studies to standardise the allocation of 
A versus K MCQs would be critically important. For the 
Medicinal Chemistry and Pharmacogenetics exam, the 
disparity in K MCQs versus A MCQs allocation between 
academics also existed, however it was much smaller 
compared to that for the Pharmaceutics exam. A total of 
17 MCQs were ranked as A by two academics, whereas, 
11 MCQs were ranked as A by the other staff. These 11 
A MCQs were among those 17 A MCQs ranked by the 
two academics. However, the students’  overall results in 
this exam were consistent for all types of MCQs, it is 
unlikely that the disparity in K MCQs versus A MCQs 
ranking affects the overall MCQ-format assessment of 
this exam. Thus,  the finding further reinforces the 
importance of setting clear criteria for MCQs, which aim 
to assess the A.
Conclusion 
Collectively, this is a primary study in the use of MCQs 
to assess the A, and its findings indicated that great 
disparity in allocation of A versus K MCQs often exists 
between academics, which could have a profound impact 
on the overall outcomes of such a study. In order to 
obtain consistent results and to expand this research area 
further, it is recommended that the following aspects be 
considered for future work, including a higher number of 
academics involved in ranking A versus K MCQs, a 
higher number of students in class,  as well as testing 
different students cohorts, for example testing students 
enrolled in the same courses in two or three follow-up 
years. More importantly, cognitive models such as 
Miller’s triangle or Bloom’s taxonomy should be used or 
applied as a guild for collaborative discussion and 
agreement between academics. Further more, clear 
criteria should be set to standardise MCQs that aim to 
assess the application of knowledge and the developed 
MCQs to be evaluated or at least tested to ensure 
consistency prior to implementation in tests and exams. 
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Appendix
Q3. A patient who received a renal transplant has been treated with 
cyclosporine to prevent the rejection of the organ. Cyclosporine 
is metabolised by CYP3A. The patient is also being treated with 
diltiazem that is a known inhibitor of CYP3A. The patient would 
like to start taking St. John’s Wort for his mild depression. St. 
John’s Wort is a known inducer of CYP3A. Which of the 
following best describes the potential drug interactions between 
cyclosporine and St John’s Wort?
a) There is no concern regarding the coadministration, as there is no 
interaction between cyclosporine and St John’s.
b) There is no concern regarding the coadministration as the patient is 
also being treated with a CYP3A inhibitor.
c) The patient should not start taking St John’s wort as it will 
decrease cyclosporine concentration due to the decrease in its 
metabolism and as a result, the patient is at significant risk of 
transplant rejection.
d) The patient should not start taking St John’s wort as it will increase 
cyclosporine concentration due to the decrease in its metabolism 
and as a result, the patient is at significant risk of transplant 
rejection.
e) The patient should not start taking St John’s wort as it will 
decrease cyclosporine concentration due to the increase in its 
metabolism and as a result, the patient is at significant risk of 
transplant rejection.
Examples of KR MCQs included in the two exams:
Q1. Which one of the following drugs has been marketed in the form 






Q2. Phase I drug metabolism reaction include:
a) Oxidation and methylation
b) Oxidation and acetylation
c) Hydrolysis and oxidation
d) Reduction and sulphation
e) Oxidation and glucuronidation
Q3. CYP2C9 refers to:
a) The gene for a cytochrome P450 belonging to superfamily 2, 
subfamily C.
b) The gene product for a cytochrome P450 belonging to family 2, 
subfamily C.
c) The gene for a cytochrome P450 belonging to superfamily 2, 
family C, subfamily 9.
d) The gene for a cytochrome P450 belonging to family 2, subfamily 
C. 
e) The gene product for a cytochrome P450 belonging to superfamily 
2, family C, subfamily 9.
Examples of AK MCQs included in the two exams:
Q1. Chloramphenicol succinate was developed as a pro-drug of 
chloramphenicol. The primary justification for its use in 
parenteral formulations is:
a) It is more stable (than chloramphenicol) to chemical degradation.
b) It is more soluble (than chloramphenicol) and therefore more 
readily given as an intravenous injection.
c) It slowly degrades to chloramphenicol, providing a sustained 
action.
d) It is less likely (than chloramphenicol) to cause thrombophlebitis 
upon injection.
e) Using the succinate enables the injection to be made isotonic.  
Q2. A drug company has recently identified and a new protein that 
they believe is an ideal drug target for the treatment of 
hypertension. In the era of pharmacogenomics ONE of the first 
investigations that should be undertaken by the company is 
which of the following?
a) Investigation for the gene that encodes for the drug target for 
genetic variability.
b) Investigation for the gene that encodes for the drug metabolising 
enzyme for genetic variability in toxicity.
c) Investigation for the gene that encodes for the drug metabolising 
enzyme for genetic variability in drug response.
d) Investigation for the gene that encodes for the drug metabolising 
enzyme for genetic variability in drug metabolism.
e) Investigation for the gene that encodes for both the drug target and 
other related molecular targets for genetic variability.
